Gene therapy using adeno-associated virus (AAV) has shown promise for treating genetic diseases yet limited by inefficient delivery. Here, the authors develop an AAV variant targeting specifically the skeletal muscle and enabling effective gene therapy for muscle diseases at significantly lower doses.
- Ai Vu Hong
- Laurence Suel
- Isabelle Richard
